Beyond The Numbers: 6 Analysts Discuss Nevro Stock
Portfolio Pulse from Benzinga Insights
Over the past three months, six analysts have shared their insights on Nevro (NYSE:NVRO), with opinions ranging from bullish to bearish. The average 12-month price target has decreased by 24.58%, reflecting a negative shift in sentiment. Analysts from firms like Morgan Stanley, Citigroup, Canaccord Genuity, Wells Fargo, and Piper Sandler have all lowered their price targets and ratings for Nevro.
July 15, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Analysts have significantly lowered their price targets for Nevro, indicating a negative shift in sentiment. The average 12-month price target has decreased by 24.58%, with ratings ranging from 'Sell' to 'Hold'.
The significant reduction in price targets and the negative shift in analyst ratings suggest a bearish outlook for Nevro in the short term. This is likely to impact the stock price negatively.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100